Global Hydroxyprogesterone Caproate Injection Market Growth 2023-2029

Global Hydroxyprogesterone Caproate Injection Market Growth 2023-2029

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
LPI (LP Information)' newest research report, the “Hydroxyprogesterone Caproate Injection Industry Forecast” looks at past sales and reviews total world Hydroxyprogesterone Caproate Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Hydroxyprogesterone Caproate Injection sales for 2023 through 2029. With Hydroxyprogesterone Caproate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydroxyprogesterone Caproate Injection industry.
This Insight Report provides a comprehensive analysis of the global Hydroxyprogesterone Caproate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hydroxyprogesterone Caproate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hydroxyprogesterone Caproate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydroxyprogesterone Caproate Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydroxyprogesterone Caproate Injection.
The global Hydroxyprogesterone Caproate Injection market size is projected to grow from US$ 257.3 million in 2022 to US$ 286.6 million in 2029; it is expected to grow at a CAGR of 286.6 from 2023 to 2029.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxyprogesterone Caproate Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
1 mL Injection(Including 1.1 mL)
5 mL Injection
Segmentation by application
Hospitals Injection
Clinics Injection
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hydroxyprogesterone Caproate Injection market?
What factors are driving Hydroxyprogesterone Caproate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hydroxyprogesterone Caproate Injection market opportunities vary by end market size?
How does Hydroxyprogesterone Caproate Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.